A Phase 2, Randomized, Double-Blind, Single-Dose, Parallel-Group, Active- and Placebo-Controlled Study of Indomethacin Test Capsules for the Treatment of Pain After Surgical Removal of Impacted Third Molars.

Trial Profile

A Phase 2, Randomized, Double-Blind, Single-Dose, Parallel-Group, Active- and Placebo-Controlled Study of Indomethacin Test Capsules for the Treatment of Pain After Surgical Removal of Impacted Third Molars.

Completed
Phase of Trial: Phase II

Latest Information Update: 22 May 2012

At a glance

  • Drugs Celecoxib; Indometacin
  • Indications Dental pain; Postoperative pain
  • Focus Therapeutic Use
  • Most Recent Events

    • 07 Nov 2011 Results have been presented at the 75th American College of Rheumatology and the 46th Annual Meeting of the Association of Rheumatology and Health Professionals, according to an Iroko Pharmaceuticals media release.
    • 07 Jan 2010 Actual end date (Dec 2009 ) added as reported by ClinicalTrials.gov.
    • 07 Jan 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top